FGFR3 protein overexpression drives tumor progression in bladder cancer, lung cancer, multiple myeloma, and glioblastoma, whereas it prevents tumor progression in cutaneous squamous cell carcinoma 25, 26. The gene discussed is FGFR3; the disease is cutaneous squamous cell carcinoma.